Positron Emission Tomography Imaging Using Copper Cu 64 TP3805 in Patients With Breast Cancer
Status: TERMINATED
Study type: INTERVENTIONAL
Conditions: Breast Carcinoma
Interventions: DEVICE: Positron Emission Mammography|DEVICE: Positron Emission Tomography|RADIATION: Fludeoxyglucose F-18|DRUG: Copper Cu 64 TP3805
Sponsor: Sidney Kimmel Cancer Center at Thomas Jefferson University
Collaborators: National Institutes of Health (NIH)